Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut 
CFPB Reaches $1.75 Million Settlement with MoneyLion Over Military Loan Overcharges 
Key Witness Seeks to Block Evidence in Potential Revival of Comey Case 
Peru’s Ex-President Martín Vizcarra Sentenced to 14 Years in Prison for Corruption 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
Afghan Suspect in Deadly Shooting of National Guard Members Faces First-Degree Murder Charge 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Northwestern University to Restore Research Funding Under $75 Million Agreement with U.S. Government 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
States Sue Trump Administration Over SNAP Restrictions for Legal Immigrants 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.
